查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
卡培他濱市場規模 - 按適應症（乳腺、結直腸、胃、胰腺）、合成類型（基於化學的 API、生物 API、高效 API、模式）、2023-2032 年全球預測
市場調查報告書
商品編碼
1394978

卡培他濱市場規模 - 按適應症（乳腺、結直腸、胃、胰腺）、合成類型（基於化學的 API、生物 API、高效 API、模式）、2023-2032 年全球預測

Capecitabine Market Size - By Indication (Breast, Colorectal, Gastric, Pancreatic), By Synthesis Type (Chemical Based API, Biological API, Highly Potent API, Mode), Global Forecast 2023- 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 162 Pages | 商品交期: 2-3個工作天內

價格

預計從 2023 年到 2032 年，卡培他濱市場規模將以 4.9% 的CAGR擴大。包括乳腺癌和結直腸癌在內的各種癌症發病率的上升正在推動對幾種有效化療藥物的需求。

癌症治療方案的快速進步正在推動卡培他濱作為口服化療方案的採用。此外，持續的研發活動以及產品批准數量的增加正在提高卡培他濱的功效和安全性。例如，2022 年 12 月，美國 FDA 批准了卡培他濱片劑的更新標籤，作為更新計畫的一部分。該計劃由腫瘤學卓越中心領導，旨在確保特定老腫瘤藥物的臨床意義和科學最新資訊。

全球人口老化的不斷加劇，加上癌症意識的增強，凸顯了卡培他濱在解決日益成長的癌症負擔方面的重要性。口服給藥的便利性和減少醫院就診以提高患者依從性是推動市場成長的其他因素。

卡培他濱產業分為適應症、合成類型、模式和地區。

根據跡象，到 2032 年，結直腸癌領域的行業價值預計將以 5.3% 的CAGR成長。結直腸癌患病率的增加和癌症治療方案的迅速進步正在推動卡培他濱作為化療方案的療效。因此，卡培他濱治療大腸直腸癌的有效性將促進該細分市場的成長。

生物 API 合成類領域的卡培他濱市場佔有率預計從 2023 年到 2032 年將以 4.9% 的CAGR成長。這種成長歸因於生物技術的不斷進步、對標靶治療的需求不斷增加以及生物合成活性藥物成分的功效。透過生物合成開發卡培他濱將進一步促進其在製藥領域的相關性和採用。

從地區來看，受乳癌和大腸癌發生率上升的推動，亞太地區卡培他濱產業預計 2023 年至 2032 年CAGR為 5.7%。醫療基礎設施的不斷進步、人們對癌症治療選擇的認知不斷提高以及人口老化的不斷成長將進一步推動該地區卡培他濱的消費。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：卡培他濱市場洞察

  • 產業生態系統分析
  • COVID-19 影響分析
  • 監管環境
    • 美國
    • 歐洲
  • 按地區分類的定價分析
    • 售價（美元/公斤）
  • 創新與永續發展
  • 產業影響力
    • 成長動力
      • 癌症發生率增加
      • 學名藥需求激增
      • 藥物相關研發活動不斷增加
    • 產業陷阱與挑戰
      • 製造成本高
  • 成長潛力分析
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 戰略展望矩陣
  • 公司市佔率分析
    • 全球的
    • 北美洲
    • 歐洲
    • 亞太地區
  • 生產能力
  • 排名前 20 名的最終消費者名單以及聯絡資訊/電子郵件 ID
  • 競爭定位矩陣

第 5 章：卡培他濱市場估計與預測：按適應症分類，2018 - 2032 年

  • 主要動向：依指示
  • 乳癌
  • 大腸直腸癌
  • 胃癌
  • 胰腺癌
  • 其他適應症

第 6 章：卡培他濱市場估計與預測：按合成類型，2018 - 2032 年

  • 主要動向：依合成型
  • 化學原料藥
  • 生物原料藥
  • 高效能 API (HPAPI)

第 7 章：卡培他濱市場估計與預測：按模式，2018 - 2032

  • 主要動向：按模式
  • 內部製造
  • 合約起草（名詞

第 8 章：卡培他濱市場估計與預測：按地區，2018 - 2032

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 俄羅斯
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 馬來西亞
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章：公司簡介

  • Sun Pharmaceutical Industries Ltd
  • Shilpa Medicare limited
  • Atom Pharma
  • Global Calcium
  • LGM Pharma
  • Dr. Reddy's Laboratories Ltd
  • Cipla Ltd
  • Zeon Pharma
  • Avanscure Lifesciences Pvt Ltd
  • Hepartex
Product Code: 6855

Capecitabine market size is projected to expand at 4.9% CAGR from 2023 to 2032. The rising incidence of various cancers, including breast and colorectal is fueling the demand for several effective chemotherapy drugs.

The rapid advancements in cancer treatment protocols is driving the adoption of capecitabine as an oral chemotherapy option. Additionally, the ongoing R&D activities along with the rising number of product approvals are leading to improved efficacy and safety of capecitabine. For instance, in December 2022, the U.S. FDA approved the updated labeling for capecitabine tablets as part of Project Renewal. This initiative, led by the Oncology Center of Excellence, aims to ensure clinically meaningful as well as scientifically up-to-date information for specific older oncology drugs.

The growing aging population across the globe coupled with the increasing cancer awareness is underscoring the significance of capecitabine in addressing the growing burden of cancer. The convenience of oral administration and reduced hospital visits for enhanced patient compliance are other factors driving the market growth.

The capecitabine industry is segregated into indication, synthesis type, mode, and region.

Based on indication, the industry value from the colorectal cancer segment is estimated to rise at 5.3% CAGR through 2032. The increasing prevalence of colorectal cancer and the surging advancements in cancer treatment protocols is driving the efficacy of capecitabine as a chemotherapy option. The effectiveness of capecitabine in treating colorectal cancer will, thus, add to the segment growth.

Capecitabine market share from the biological API synthesis type segment is projected to increase at 4.9% CAGR from 2023 to 2032. This growth is ascribed to the growing advancements in biotechnology, the increasing demand for targeted therapies, and the efficacy of biologically synthesized active pharmaceutical ingredients. The development of capecitabine through biological synthesis will further contribute to its relevance and adoption in the pharmaceutical sector.

Regionally, the Asia Pacific capecitabine industry is slated to expand at 5.7% CAGR from 2023 to 2032, driven by the increasing incidence of breast and colorectal cancers. The rising advancements in healthcare infrastructure, increasing awareness of cancer treatment options, and the growing aging population will further drive the consumption of capecitabine across the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Capecitabine market 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Indication trends
    • 2.1.4 Synthesis type trends
    • 2.1.5 Mode trends

Chapter 3 Capecitabine Market Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 COVID-19 impact analysis
  • 3.3 Regulatory landscape
    • 3.3.1 U.S.
    • 3.3.2 Europe
  • 3.4 Pricing analysis, by region (USD Million)
    • 3.4.1 Selling price in USD per kg
  • 3.5 Innovation & sustainability
  • 3.6 Industry impact forces
    • 3.6.1 Growth drivers
      • 3.6.1.1 Increasing incidences of cancer
      • 3.6.1.2 Surging demand for generics
      • 3.6.1.3 Rising drug related research and development activities
    • 3.6.2 Industry pitfalls & challenges
      • 3.6.2.1 High manufacturing cost
  • 3.7 Growth potential analysis
    • 3.7.1 By indication
    • 3.7.2 By synthesis type
    • 3.7.3 By mode
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Strategic outlook matrix, 2022
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Production capacity
  • 4.5 List of top 20 end consumers with contact details/email id
  • 4.6 Competitive positioning matrix, 2022

Chapter 5 Capecitabine Market Estimates and Forecast, By Indication, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by indication
  • 5.2 Breast cancer
  • 5.3 Colorectal cancer
  • 5.4 Gastric cancer
  • 5.5 Pancreatic cancer
  • 5.6 Other indications

Chapter 6 Capecitabine Market Estimates and Forecast, By Synthesis Type, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by synthesis type
  • 6.2 Chemical based API
  • 6.3 Biological API
  • 6.4 Highly potent API (HPAPI)

Chapter 7 Capecitabine Market Estimates and Forecast, By Mode, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by mode
  • 7.2 In-house manufacturing
  • 7.3 Contract manufacturing

Chapter 8 Capecitabine Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Russia
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Malaysia
    • 8.4.7 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Sun Pharmaceutical Industries Ltd
  • 9.2 Shilpa Medicare limited
  • 9.3 Atom Pharma
  • 9.4 Global Calcium
  • 9.5 LGM Pharma
  • 9.6 Dr. Reddy's Laboratories Ltd
  • 9.7 Cipla Ltd
  • 9.8 Zeon Pharma
  • 9.9 Avanscure Lifesciences Pvt Ltd
  • 9.10 Hepartex

Data Tables

  • TABLE 1 Market revenue, by indication (2022)
  • TABLE 2 Market revenue, by synthesis type (2022)
  • TABLE 3 Market revenue, by mode (2022)
  • TABLE 4 Market share, by region (2022)
  • TABLE 5 Global capecitabine market size, 2018 - 2024 (USD Million)
  • TABLE 6 Global capecitabine market size, 2025 - 2032 (USD Million)
  • TABLE 7 Global capecitabine market size, by region, 2018 - 2024 (USD Million)
  • TABLE 8 Global capecitabine market size, by region, 2025 - 2032 (USD Million)
  • TABLE 9 Global capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 10 Global capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 11 Global capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 12 Global capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 13 Global capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 14 Global capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 15 Capecitabine selling price per KG, by region 2022
  • TABLE 16 Industry impact forces
  • TABLE 17 Production capacity, 2022
  • TABLE 18 List of top 20 end consumers with contact details/email id
  • TABLE 19 Competitive positioning matrix: Classification criteria
  • TABLE 20 Breast cancer market size, 2018 - 2024 (USD Million)
  • TABLE 21 Breast cancer market size, 2025 - 2032 (USD Million)
  • TABLE 22 Colorectal cancer market size, 2018 - 2024 (USD Million)
  • TABLE 23 Colorectal cancer market size, 2025 - 2032 (USD Million)
  • TABLE 24 Gastric cancer market size, 2018 - 2024 (USD Million)
  • TABLE 25 Gastric cancer market size, 2025 - 2032 (USD Million)
  • TABLE 26 Pancreatic cancer market size, 2018 - 2024 (USD Million)
  • TABLE 27 Pancreatic cancer market size, 2025 - 2032 (USD Million)
  • TABLE 28 Other indications market size, 2018 - 2024 (USD Million)
  • TABLE 29 Other indications market size, 2025 - 2032 (USD Million)
  • TABLE 30 Chemical based API market size, 2018 - 2024 (USD Million)
  • TABLE 31 Chemical based API market size, 2025 - 2032 (USD Million)
  • TABLE 32 Biological API market size, 2018 - 2024 (USD Million)
  • TABLE 33 Biological API market size, 2025 - 2032 (USD Million)
  • TABLE 34 Highly potent API (HPAPI) market size, 2018 - 2024 (USD Million)
  • TABLE 35 Highly potent API (HPAPI) market size, 2025 - 2032 (USD Million)
  • TABLE 36 In-house manufacturing market size, 2018 - 2024 (USD Million)
  • TABLE 37 In-house manufacturing market size, 2025 - 2032 (USD Million)
  • TABLE 38 Contract manufacturing market size, 2018 - 2024 (USD Million)
  • TABLE 39 Contract manufacturing market size, 2025 - 2032 (USD Million)
  • TABLE 40 North America capecitabine market size, by country, 2018 - 2024 (USD Million)
  • TABLE 41 North America capecitabine market size, by country, 2025 - 2032 (USD Million)
  • TABLE 42 North America capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 43 North America capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 44 North America capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 45 North America capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 46 North America capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 47 North America capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 48 U.S. capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 49 U.S. capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 50 U.S. capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 51 U.S. capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 52 U.S. capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 53 U.S. capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 54 Canada capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 55 Canada capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 56 Canada capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 57 Canada capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 58 Canada capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 59 Canada capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 60 Europe capecitabine market size, by country, 2018 - 2024 (USD Million)
  • TABLE 61 Europe capecitabine market size, by country, 2025 - 2032 (USD Million)
  • TABLE 62 Europe capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 63 Europe capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 64 Europe capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 65 Europe capecitabine market size, by synthesis type, 2025-2032 (USD Million)
  • TABLE 66 Europe capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 67 Europe capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 68 Germany capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 69 Germany capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 70 Germany capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 71 Germany capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 72 Germany capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 73 Germany capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 74 UK capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 75 UK capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 76 UK capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 77 UK capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 78 UK capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 79 UK capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 80 France capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 81 France capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 82 France capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 83 France capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 84 France capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 85 France capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 86 Spain capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 87 Spain capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 88 Spain capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 89 Spain capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 90 Spain capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 91 Spain capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 92 Italy capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 93 Italy capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 94 Italy capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 95 Italy capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 96 Italy capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 97 Italy capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 98 Russia capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 99 Russia capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 100 Russia capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 101 Russia capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 102 Russia capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 103 Russia capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 104 Rest of Europe capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 105 Rest of Europe capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 106 Rest of Europe capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 107 Rest of Europe capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 108 Rest of Europe capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 109 Rest of Europe capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 110 Asia Pacific capecitabine market size, by country, 2018 - 2024 (USD Million)
  • TABLE 111 Asia Pacific capecitabine market size, by country, 2025 - 2032 (USD Million)
  • TABLE 112 Asia Pacific capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 113 Asia Pacific capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 114 Asia Pacific capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 115 Asia Pacific capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 116 Asia Pacific capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 117 Asia Pacific capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 118 Japan capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 119 Japan capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 120 Japan capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 121 Japan capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 122 Japan capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 123 Japan capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 124 China capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 125 China capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 126 China capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 127 China capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 128 China capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 129 China capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 130 India capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 131 India capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 132 India capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 133 India capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 134 India capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 135 India capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 136 Australia capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 137 Australia capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 138 Australia capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 139 Australia capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 140 Australia capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 141 Australia capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 142 South Korea capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 143 South Korea capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 144 South Korea capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 145 South Korea capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 146 South Korea capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 147 South Korea capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 148 Malaysia capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 149 Malaysia capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 150 Malaysia capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 151 Malaysia capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 152 Malaysia capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 153 Malaysia capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 154 Rest of Asia Pacific capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 155 Rest of Asia Pacific capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 156 Rest of Asia Pacific capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 157 Rest of Asia Pacific capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 158 Rest of Asia Pacific capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 159 Rest of Asia Pacific capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 160 Latin America capecitabine market size, by country, 2018 - 2024 (USD Million)
  • TABLE 161 Latin America capecitabine market size, by country, 2025 - 2032 (USD Million)
  • TABLE 162 Latin America capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 163 Latin America capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 164 Latin America capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 165 Latin America capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 166 Latin America capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 167 Latin America capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 168 Brazil capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 169 Brazil capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 170 Brazil capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 171 Brazil capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 172 Brazil capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 173 Brazil capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 174 Mexico capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 175 Mexico capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 176 Mexico capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 177 Mexico capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 178 Mexico capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 179 Mexico capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 180 Rest of Latin America capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 181 Rest of Latin America capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 182 Rest of Latin America capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 183 Rest of Latin America capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 184 Rest of Latin America capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 185 Rest of Latin America capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 186 Middle East & Africa capecitabine market size, by country, 2018 - 2024 (USD Million)
  • TABLE 187 Middle East & Africa capecitabine market size, by country, 2025 - 2032 (USD Million)
  • TABLE 188 Middle East & Africa capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 189 Middle East & Africa capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 190 Middle East & Africa capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 191 Middle East & Africa capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 192 Middle East & Africa capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 193 Middle East & Africa capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 194 Saudi Arabia capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 195 Saudi Arabia capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 196 Saudi Arabia capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 197 Saudi Arabia capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 198 Saudi Arabia capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 199 Saudi Arabia capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 200 South Africa capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 201 South Africa capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 202 South Africa capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 203 South Africa capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 204 South Africa capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 205 South Africa capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 206 UAE capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 207 UAE capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 208 UAE capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 209 UAE capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 210 UAE capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 211 UAE capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 212 Rest of Middle East & Africa capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 213 Rest of Middle East & Africa capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 214 Rest of Middle East & Africa capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 215 Rest of Middle East & Africa capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 216 Rest of Middle East & Africa capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 217 Rest of Middle East & Africa capecitabine market size, by mode, 2025 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Bottom-up approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Capecitabine industry 3600 synopses, 2018 - 2032
  • FIG 7 Capecitabine market ecosystem
  • FIG 8 Growth potential analysis, by indication
  • FIG 9 Growth potential analysis, by synthesis type
  • FIG 10 Growth potential analysis, by mode
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Strategic outlook matrix, 2022
  • FIG 14 Global company market share, 2022
  • FIG 15 North America company market share, 2022
  • FIG 16 Europe company market share, 2022
  • FIG 17 Asia Pacific company market share, 2022
  • FIG 18 Competitive positioning matrix, 2022